HomeOGN • NYSE
add
Organon & Co
Previous close
$7.06
Day range
$6.97 - $7.58
Year range
$6.18 - $16.50
Market cap
1.92B USD
Avg Volume
6.20M
P/E ratio
3.84
Dividend yield
1.08%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.51B | -5.34% |
Operating expense | 524.00M | -12.96% |
Net income | -205.00M | -288.07% |
Net profit margin | -13.60 | -298.54% |
Earnings per share | 0.63 | -30.00% |
EBITDA | 327.00M | -11.86% |
Effective tax rate | -38.51% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 672.00M | -0.44% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 906.00M | — |
Shares outstanding | 259.98M | — |
Price to book | 2.03 | — |
Return on assets | — | — |
Return on capital | 6.04% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -205.00M | -288.07% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Founded
1923
Headquarters
Website
Employees
10,000
